DRKS00030290招募中不适用
Creation of a clinically annotated, multimodal biosignal database of endoscopy sedation - Endoscopy biosignal database
niversitätsklinikum Halle (Saale)0 个研究点目标入组 1,272 人开始时间: 2024年1月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,272
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Persons of full age who are capable of giving consent and who have undergone elective endoscopy under sedation and anticipated endoscopy duration of at least 20 minutes are included.
排除标准
- •A known structural brain disease, cerebral neoplasia or cerebral metastatic malignancy, a known seizure disorder or impaired consciousness with Glagow Coma Scale < 15 are exclusion criteria. Furthermore, patients with profound hearing loss or allergies to the sedatives administered are excluded.
研究者
相似试验
招募中
不适用
@neurIST Integrated biomedical informatics for the management of intracranial aneurysmsarterial bulgingarterial widening1000796310002363NL-OMON30929Erasmus MC, Universitair Medisch Centrum Rotterdam100
尚未招募
Unknown
Cohort for multimodal data acquisition in patients with cerebrovascular diseasesKCT0009474Samsung Medical Center210
已完成
不适用
Development of integrated database with clinical, radiological and pathological data of idiopatihc interstitial pneumonias (IIPs) for multidisciplinary discussionsidiopatihc interstitial pneumoniasJPRN-UMIN000028192Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine500
招募中
不适用
Construction of database and analysis of clinical condition of spinal muscular atrophy in NHO Osaka Toneyama Medical Centerspinal muscular atrophyJPRN-UMIN000041696ational Hospital Organization Osaka Toneyama Medical Center50
进行中（未招募）
1 期
A clinical study with biopsy to investigate how ianalumab works in Sjögren`s and how safe it isMedDRA version: 21.0Level: PTClassification code 10040767Term: Sjogren's syndromeSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersSjögren's syndromeEUCTR2020-005055-20-FRovartis Pharma AG24